StonvexLoading…
StonvexStonvexStonvexCore line items from GRNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $128.26M | $450.31M | $344.82M | $232.15M |
Operating Income | $14.85M | $46.42M | $82.86M | $63.27M |
Net Income | $-47.03M | $24.35M | $49.42M | $25.08M |
EPS (Diluted) | $-0.36 | $0.18 | $0.38 | $0.27 |
Total Assets | $1.19B | $1.17B | $1.13B | $1.10B |
Total Liabilities | $648.24M | $562.31M | $484.65M | $462.50M |
Cash & Equivalents | $30.06M | $14.85M | $11.83M | $3.74M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 130.62M | 130.50M | 130.50M | 130.50M |